Is Wegovy a Pill or an Injection? (It's Now Both)
- Ali Salih
- Jul 17
- 7 min read
Updated: Jul 22
Written by the ClariDay clinical team. Medically reviewed by Ali Salih, GPhC-registered Pharmacist Independent Prescriber. Reviewed 16 July 2026. Next review 16 August 2026
Wegovy is now available in two forms. It began as a weekly injection, and on 11 June 2026 the UK medicines regulator, the MHRA, licensed a once-daily tablet, oral semaglutide 25mg, the country's first weight-loss pill [1].
It is the same medicine either way. So the question is not which form exists, but which of the two suits you.
Key takeaways
So has the injection been replaced?
No, it has not. The tablet is an addition, not a replacement. Both contain the same medicine, semaglutide, and both do the same thing: they reduce appetite, quietening the background sense of hunger that many people call "food noise", so that you feel full sooner and eat less without it being a constant effort [1]. What has changed is only the way the medicine is taken.
The injection is not being withdrawn. It has the longer record of use, and for many people it remains the sensible choice. The tablet simply provides a second route to the same result. The decision between them is, in practice, about which one fits your life.
What changed in June 2026?
Until the summer of 2026, Wegovy was available in one form only: a weekly injection under the skin, from a pre-filled pen. On 11 June 2026 the MHRA licensed the tablet form, oral semaglutide taken once a day, and described it as the first GLP-1 weight-loss tablet approved in the UK [1]. If you would like the tablet itself explained in full, our guide to what the Wegovy pill is and how it works sets it out.
One distinction is worth being clear about, because it is often misunderstood. Being licensed is not the same as being funded. The tablet is approved for use, but it is not currently available on the NHS; that decision awaits a separate review by NICE, the body that decides what the health service pays for [1]. For the time being, it is a private-prescription medicine. We set out both routes, and whether you are eligible for the tablets privately, in the wider Wegovy tablets guide.
The daily routine is where people trip up
Most people assume a tablet must be the easier option. In practice, it asks more of you each morning than the injection does.
The tablet has to be taken first thing, on an empty stomach, with no more than a small glass of water, about 120ml, and then followed by nothing at all, no food, no coffee, no other medicine, for at least 30 minutes [5]. This is not caution for its own sake. The tablet is only absorbed on an empty stomach, within that short window; eat or drink too soon, and most of the dose is lost [2, 5].
So those 30 minutes are not a polite suggestion. They are part of the treatment. Our full guide to how to take Wegovy tablets goes through the routine step by step.
The injection carries none of this. It is given under the skin, once a week, at whatever time suits you, with or without food.
The two forms at a glance
Do the two doses work the same way?
No, they do not. The schedules differ, and one point is genuinely useful to know. The tablet is taken daily; the injection weekly. Both are started at a low dose and increased in steps, to let the body adjust and to keep the early side effects mild. The tablet moves up through 1.5mg, then 4mg, 9mg and finally 25mg once daily, spending at least a month at each step [1]. The injection has its own separate schedule up to its full weekly dose.
If you are already on the full 2.4mg weekly injection, you can move straight to the 25mg daily tablet, without starting again at the lowest dose [1]. Our clinician's guide to switching from the injection to tablets explains how that is done safely.
Does the tablet work as well as the injection?
On the evidence so far, broadly yes, though it is worth being precise. In the tablet's main trial, OASIS 4, people lost about 14% of their body weight on average over roughly 15 months, compared with about 2% on a dummy tablet, and about a third lost at least a fifth of their weight [3]. For a 16-stone (100kg) adult, that average is a little over two stone. The injection's main trial, STEP 1, produced an average of about 14.9% over a similar period [4].
The figures are close. But the two forms have not been compared directly in the same trial, so the accurate statement is that the tablet produces results in the same range as the injection, not that it has been shown to be equal to it [6]. It is also sensible to be realistic: results in trials, where people are closely supported, tend to be somewhat better than results in ordinary use.
Is the injection gentler on the stomach?
A common hope is that the tablet will be gentler on the stomach. On the evidence, it is not, and the reason is straightforward: the nausea some people feel comes from the medicine itself, not from the way it is taken.
The effects are mostly digestive, some nausea and changes to the stomach and bowel, mainly in the first few weeks and after each rise in dose. They are usually mild, and they tend to settle as the body adjusts. In the tablet's trial, about three in four people had some digestive effect, most of it minor [3]; in the injection's trial, the commonest was nausea, in roughly four in ten [4]. Those figures count different things and come from separate trials, so they are not a direct comparison. What they show is simply that neither form avoids side effects altogether.
The more useful figure, when you are deciding, is a different one. In both trials, only about one in fifteen people stopped because of side effects, barely more than on a dummy treatment [3, 4]. For most people, the early nausea settles as the body adjusts. Side effects, then, are rarely the deciding factor between the two. If a sensitive stomach is your particular concern, it is worth saying so before you start: on either form, the dose can be increased more slowly to make the early weeks easier.
Wegovy pill or injection: which should you choose?
Since the medicine is the same, the results are in the same range, and the side effects are broadly comparable, the decision is not, in the end, a medical one. It rests on how each option fits into your week.
In short: the tablet removes the needle and rewards a settled morning; the weekly injection asks far less of an unpredictable one, and that reliability is easy to underrate until you are a fortnight in.
Beyond that, it is your medical history and any other medicines you take that shape the decision, which is why it is worth a short conversation with a prescriber before you start, rather than a judgement made alone.
From the Clinic
Ali Salih Pharmacist Independent Prescriber
Frequently asked questions
Is Wegovy a pill or an injection?
It is both. Wegovy started as a once-weekly injection and, since 11 June 2026, is also available in the UK as a once-daily tablet, oral semaglutide 25mg [1]. Both contain the same medicine.
Does Wegovy really come in pill form now?
Yes, it does. The MHRA licensed the Wegovy tablet on 11 June 2026, as the first GLP-1 weight-loss tablet approved in the UK [1].
Is the Wegovy tablet available on the NHS?
Not currently available on the NHS. It is licensed but not yet funded; that decision follows a NICE review, so for now it is a private-prescription option [1].
Can I switch from the Wegovy injection to the tablet?
It is possible. People on the full 2.4mg weekly injection can move directly to the 25mg daily tablet [1]. It should always be done with your prescriber.
Is the tablet as effective as the injection?
In their separate trials the average weight loss was similar, about 14% for the tablet and about 14.9% for the injection [3, 4]. But because they were never compared head to head, this is a broad comparison, not proof that one equals the other [6].
Does the injection have fewer side effects than the tablet?
No, not meaningfully. Both cause digestive effects such as nausea in a large share of people, because it is the same medicine working the same way. The injection is not the gentler option [3, 4].
Why does the tablet have to be taken on an empty stomach?
Because the absorption enhancer that lets it work only does so on an empty stomach with a small sip of plain water. Food or other drinks stop most of the dose being absorbed [2, 5].
If you are considering treatment
If you are weighing up the tablet against the injection, the most useful next step is a short conversation with a prescriber, who can consider your history and help you choose. You can book a consultation with a ClariDay prescriber.
This article is general information, not medical advice, and is not a substitute for a consultation with a qualified prescriber.
References
[1] Medicines and Healthcare products Regulatory Agency. (2026, June 11). First GLP-1 tablet for weight loss approved in the UK. GOV.UK. Retrieved 16 July 2026, from https://www.gov.uk/government/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk
[2] Twarog, C., & Overgaard, R. V. (2023). Current understanding of sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) as an absorption enhancer: The oral semaglutide experience. Clinical Diabetes, 41(1). https://doi.org/10.2337/cd22-0118 (Accessed 16 July 2026.)
[3] Wharton, S., et al. (2025). Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2500969. Figures cross-checked against American College of Cardiology journal scan, 24 September 2025, https://www.acc.org/latest-in-cardiology/journal-scans/2025/09/24/16/40/oasis-4 (Accessed 16 July 2026.)
[4] Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183. (Accessed 16 July 2026.)
[5] Novo Nordisk. Summary of Product Characteristics: oral semaglutide (Rybelsus), Method of administration. electronic medicines compendium (emc). Retrieved 16 July 2026, from https://www.medicines.org.uk/emc/product/11507/smpc. Quoted: "It should be swallowed whole with a sip of water (up to half a glass of water equivalent to 120 mL)"; "Patients should wait at least 30 minutes before eating, drinking or taking other oral medicinal products."
[6] Comparison note: Direct efficacy comparisons between oral semaglutide 25 mg and injectable semaglutide 2.4 mg are indirect (cross-trial), not head-to-head. Diabetes, Obesity and Metabolism (2025), indirect treatment comparison, https://doi.org/10.1111/dom.70911 (Accessed 16 July 2026.)
Comments